G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 124 filers reported holding G1 THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $132 | -78.4% | 49,297 | -56.3% | 0.00% | -83.3% |
| Q4 2022 | $612 | -99.9% | 112,746 | +34.0% | 0.01% | -47.8% |
| Q3 2022 | $1,051,000 | +373.4% | 84,119 | +87.1% | 0.02% | +283.3% |
| Q2 2022 | $222,000 | -62.2% | 44,964 | +37.9% | 0.01% | -64.7% |
| Q4 2020 | $587,000 | +90.0% | 32,607 | +22.0% | 0.02% | +30.8% |
| Q3 2020 | $309,000 | +13.2% | 26,732 | +411.4% | 0.01% | +85.7% |
| Q3 2018 | $273,000 | – | 5,227 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 994,287 | $19,041,000 | 1.55% |
| HHLR ADVISORS, LTD. | 949,431 | $18,182,000 | 0.75% |
| BB BIOTECH AG | 671,925 | $12,867,000 | 0.41% |
| Rhenman & Partners Asset Management AB | 172,820 | $3,310,000 | 0.38% |
| Birchview Capital, LP | 15,000 | $287,000 | 0.27% |
| Rock Springs Capital Management LP | 100,000 | $1,915,000 | 0.09% |
| SECOR Capital Advisors, LP | 32,591 | $624,000 | 0.08% |
| MARSHALL WACE, LLP | 386,510 | $7,402,000 | 0.08% |
| SIGNATUREFD, LLC | 37,942 | $727,000 | 0.07% |
| A.R.T. Advisors, LLC | 38,125 | $730,000 | 0.05% |